Form 4: ProMIS Neurosciences Director Patrick Kirwin Acquires 10,000 Shares
SEC Form 4 Filing
Director Patrick Kirwin of ProMIS Neurosciences Inc. reports the acquisition of 10,000 common shares at $1.2492 per share.
Summary
- On August 14, 2024, Patrick D. Kirwin, a director of ProMIS Neurosciences Inc., purchased 10,000 common shares of the company at a price of $1.2492 per share.
- Following this transaction, Kirwin directly owns 62,983 common shares.
- Kirwin also indirectly owns 27,998 shares through Patrick D. Kirwin Professional Corp, 2,383 shares through Patrick Kirwin TFSA, and 5,732 shares by his spouse.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of a director's stock purchase. While insider buying can be seen as a positive signal, it's not overwhelmingly positive without additional context.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This is a standard disclosure related to insider trading. It is common for directors and officers of publicly traded companies to buy and sell shares of their company, and these transactions must be reported to the SEC.
Stakeholder Impact
- The purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 08/14/2024 | Date of transaction: Patrick Kirwin acquired 10,000 common shares. |
| 08/16/2024 | Date of report: Form 4 filing date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.